At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
The Dow Jones Industrial Average rallied from a low of 12751.51 to a high of 12858, but the daily chart remains negative. The NASDAQ rallied from a low of 2920.54 to a high of 1940.28, but the
Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiX testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
Website: | www.aspirawh.com |
Email: | Arr@lifesciadvisors.com |
Main Phone: | +1 512 519-0400 |
Address: | 12117 Bee Caves Road, Building Three |
Address 2: | Suite 100 |
State: | TX |
City / Town: | Austin |
Country: | US |
Postal Code: | 78738 |
Exchange: | NSC |
CEO: | Valerie Palmieri |
Employees: | 53 |
NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
The Dow Jones Industrial Average rallied from a low of 12751.51 to a high of 12858, but the daily chart remains negative. The NASDAQ rallied from a low of 2920.54 to a high of 1940.28, but the
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
|
|
Last 3 Mo | Last 12 Mo | |
---|---|---|
Number of Insider Trades | 10 | 20 |
Number of Buys | 10 | 20 |
Number of Sells | 0 | 0 |
Net Activity | 5344264 | 8061903 |
Last 10 Buys | Shares |
---|---|
Henri George Schuler | 1,000 |
Henri George Schuler | 1,000 |
Henri George Schuler | 1,000 |
Jack W Schuler | 1,000 |
Henri George Schuler | 1,000 |
Valerie Palmieri | 1,000 |
Valerie Palmieri | 1,000 |
Valerie Palmieri | 1,000 |
Valerie Palmieri | 1,000 |
Valerie Palmieri | 1,000 |
Last 10 Sell | Shares |
---|---|
Carl Severinghaus | 1,000 |
Carl Severinghaus | 1,000 |
Carl Severinghaus | 1,000 |
Gail S. Page | 1,000 |
Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
---|---|---|---|---|
High Target Price Estimate | 2.25 | 2.25 | 2.25 | 2.25 |
Low Target Price Estimate | 2.25 | 2.25 | 2.25 | 2.25 |
Mean Target Price Estimate | 2.25 | 2.25 | 2.25 | 2.25 |
Standard Deviation | 0 | 0 | 0 | 0 |
Date of Most Recent Estimate | 11/02/17 | 11/02/17 | 11/02/17 | 11/02/17 |
Form Type | Form Description | Pages | Date |
---|---|---|---|
8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-05-30 |
10-Q | Quarterly report with a continuing view of a company's financial position | 32 | 2018-05-14 |
8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-05-14 |
DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 81 | 2018-05-11 |
10-K/A | Amendment to a previously filed 10-K | 29 | 2018-04-30 |
PRE 14A | Preliminary proxy statement providing notification matters to be brought to a vote | 81 | 2018-04-27 |
SC 13D/A | Amendment to a SC 13D filing | 10 | 2018-04-23 |
SC 13D/A | Amendment to a SC 13D filing | 8 | 2018-04-19 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-19 |
SC 13D/A | Amendment to a SC 13D filing | 10 | 2018-04-19 |
Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Strong Buy | 0 | 1 | 1 | 1 |
Moderate Buy | 0 | 0 | 0 | 0 |
Hold | 1 | 0 | 0 | 0 |
Moderate Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Mean Rec. | 3 | 1 | 1 | 1 |